tiprankstipranks
Seelos Therapeutics (SEEL)
OTHER OTC:SEEL
Holding SEEL?
Track your performance easily

Seelos Therapeutics (SEEL) Income Statement

1,218 Followers

Seelos Therapeutics Income Statement

Last quarter (Q2 2024), Seelos Therapeutics's total revenue was $376.00K, a decrease of -53.47% from the same quarter last year. In Q2, Seelos Therapeutics's net income was $1.71M. See Seelos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.29M$ 2.20M---$ 375.00K
Cost of Revenue
------
Gross Profit
$ 1.70M$ 2.20M---$ 151.00K
Operating Expense
$ 34.45M$ 40.50M$ 70.92M$ 61.67M$ 18.76M$ -30.12M
Operating Income
$ -32.75M$ -40.50M$ -70.92M$ -61.67M$ -18.76M$ -34.99M
Net Non Operating Interest Income Expense
$ 64.00K$ 123.00K$ 107.00K$ -1.49M$ -119.00K$ -138.00K
Other Income Expense
$ -12.18M$ 2.49M$ -2.73M$ 2.89M$ 223.00K$ 16.13M
Pretax Income
$ -19.13M$ -37.88M$ -73.53M$ -66.05M$ -19.10M$ -51.26M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -19.95M$ -75.76M$ -73.53M$ -66.05M$ -19.10M$ -51.26M
Basic EPS
$ -552.32$ -989.44$ -2.65K$ -2.80K$ -1.65K-
Diluted EPS
$ -1.33K$ -989.44$ -2.65K$ -2.80K$ -1.65K$ -9.68K
Basic Average Shares
$ 327.87K$ 38.28K$ 27.69K$ 23.67K$ 11.66K$ 5.29K
Diluted Average Shares
$ 331.76K$ 38.28K$ 27.69K-$ 11.66K$ 5.30K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 34.45M$ 40.50M$ 70.92M$ 61.67M$ 18.76M$ -30.12M
Net Income From Continuing And Discontinued Operation
$ -19.95M$ -37.88M$ -73.53M$ -66.05M$ -19.10M$ -51.26M
Normalized Income
$ -2.11M--$ -48.41M--
Interest Expense
------
EBIT
$ -19.66M$ -37.81M$ -73.52M$ -64.45M$ -18.94M$ -51.23M
EBITDA
$ -19.60M$ -37.75M$ -73.47M$ -64.45M$ -18.94M$ -51.23M
Currency in USD

Seelos Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis